nTech Sponsors FOSE 2012

April 03, 2012 05:18 PM Eastern Daylight Time nTech Solutions Sponsors FOSE 2012, Apr 3 – 5, 2012, in Washington DC, US ELLICOTT CITY, Md.–(BUSINESS WIRE)–Press Kit Materials are Available at: http://www.tradeshownews.com/events/FOSE-2012/ntechsol/ Company: nTech Solutions Event: FOSE 2012 Apr 3 – 5, 2012 Washington, DC, US Web: http://www.ntechsol.com About nTech Solutions nTech Solutions is a global technology services provider, delivering business solutions to its customers. ntech delivers one of the industry’s broadest portfolios of information technology and business process consulting and outsourcing services to customers in the manufacturing, financial services, healthcare, communications, energy, transportation, and consumer and retail industries, and to governments around the world. nTech Solutions specializes in identifying high quality talent with technology experience and providing services to organization in need of IT support. We are a Minority Based Entrepreneur (MBE) and GSA certified company. Certified by the National Minority Supplier Development Council Inc (NMSDC). Contacts nTech Solutions Company Contact: Kenn Raatjes, 443-865-2260 kraatjes@ntechsol.com or PR Contact: Dawn Borkowski, 410-505-8388 dawn.borkowski@ntechsol.com http://www.businesswire.com/news/home/20120403006968/en/nTech-Solutions-Sponsors-FOSE-2012-Apr-3

nTech Donates to Parkinson Foundation

On behalf of CEO Todd Sherer, PhD, the Board of Directors and the scientists and staff of The Michael J. Fox Foundation for Parkinson’s Research, I am delighted to thank you for your 4/30/2012 gift of $250.00. The generosity of supporters like you makes it possible for us to continue our efforts on behalf of the nearly five million people living with Parkinson’s worldwide.   MJFF continues to be a catalyst for translational research and a highly informed field leader. Our innovative and strategic funding approach re-thinks, and continually reevaluates, how focused resources can really make a difference. Sitting at the hub of global Parkinson’s disease research, we use all resources at our disposal — financial, intellectual, collaborative — to accelerate the movement of basic discoveries from the laboratory table to clinical testing and pharmacy shelves.   Thank you again for joining us in our aggressive pursuit of transformative treatments – and ultimately a cure – for Parkinson’s disease. I look forward to keeping you apprised of our progress. With gratitude, The Michael J. Fox Foundation for Parkinson’s Research